Sign-up for Ohr Pharmaceutical Announces New Positive Anatomic and Visual Acuity Data on OHR-102 (Squalamine Eye Drops) IMPACT Study Presented at the 2014 American Academy of Ophthalmology Scientific Meeting investment picks
Comverse's Newest European Data Facility Powering Cloud-Based VAS and Advanced Digital Services
Comverse inaugurates new ultra-modern data center in Europe to accommodate growing customer demand for cloud/ virtualized solutions
In parallel, Comverse expands availability of SaaS subscription-based models of its leading VAS, Evolved Communication Suite and BSS offerings
Cloud-based SaaS engagement models enable communication service providers (CSPs) to upgrade existing services and launch compelling new services at reduced cost and risk, with fast time to monetization
WAKEFIELD, Mass., Oct.
Third quarter production of 169.7 MMcfe/d exceeds high end of company guidance by 3%; represents a 32% sequential increase in average daily production over the second quarter of 2014 and 72% over the second quarter of 2013 Average daily production from oil, condensate and NGLs (including ethane) reached a record level of 10.4 MBoe/d, a 61% increase over the second quarter of 2014 Record oil and condensate production of 3.3 Mboe/d, a 20% increase over the second quarter of 2014 Full year 2014 production guidance increased by 2% at the midpoint of the guidance range
STATE COLLEGE, Pa., Oct.
Sign-up for Rex Energy Provides Third Quarter Production Results, Increases Full Year 2014 Production Guidance, Updates 2015 Hedge Position and Announces Date of Third Quarter Earnings Release investment picks
Sign-up for NewLink Genetics Announces Exclusive Worldwide Licensing Agreement for Development of NLG919, an IDO Inhibitor in Phase 1, and Research Collaboration for the Discovery of Next Generation IDO/TDO Inhibitors investment picks
Sign-up for Apricus Expands Development Pipeline With the In-Licensing of U.S. Rights for Fispemifene, a Phase 2b Ready Asset, From Forendo Pharma Targeting Urological Conditions in Men investment picks
Sign-up for SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Marrone Bio Innovations, Inc. of Class Action Lawsuit and Upcoming Deadline -- MBII investment picks
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.